The Particulars: Surgery is typically the indicated initial treatment of loco-regional non-small cell lung cancer (NSCLC). Data are lacking on how surgical management of NSCLC varies by race.
Data Breakdown: For a study, 1.2 million patients were assessed following their first course of treatment after an initial NSCLC diagnosis. Surgical intervention was performed in 78% of Caucasians, 73% of African Americans, and 82% of Hispanics with stage I disease. Corresponding rates for stage II disease were 64%, 56%, and 67%.
Take Home Pearls: Racial disparities appear to be prevalent in the surgical management of patients with loco-regional NSCLC. African-Americans appear to be less likely to undergo surgery when compared with Caucasians and Hispanics.
